Skip to main content

Quantifying the impact of early-life growth adversity on later-life health.

Publication ,  Journal Article
Goldman-Pham, R; Alter, MP; Bao, R; Collins, SÉ; Debban, CL; Allinson, JP; Ambler, A; Bertoni, AG; Caspi, A; Lovinsky-Desir, S; Ekstrom, MP ...
Published in: medRxiv
June 17, 2025

BACKGROUND: Early-life growth adversity is important to later-life health, but precision assessment in adulthood is challenging. We evaluated whether the difference between attained and genotype-predicted adult height ("height-GaP") would associate with prospectively ascertained early-life growth adversity and later-life all-cause and cardiovascular mortality. METHODS: Data were first analyzed from the Avon Longitudinal Study of Parents and Children (ALSPAC) and UKBiobank. Genotype-predicted height was calculated using a multi-ancestry polygenic height score. Height-GaP was calculated as the difference between measured and genotype-predicted adult height. Early-life growth conditions were ascertained prospectively via standardized procedures (ALSPAC) and mortality via death register (UKBiobank). Regression models adjusted for age, sex, genotype-predicted height and genetic ancestry. Analyses were replicated in the Dunedin Multidisciplinary Health and Development Study (DMHDS) and the Multi-Ethnic Study of Atherosclerosis (MESA). FINDINGS: Among 4,582 ALSPAC participants (median [IQR] age: 24[18-25] years at height-GaP assessment), lower gestational age at birth, greater pre- and post-natal deprivation indices, tobacco smoke exposure and less breastfeeding were associated with larger adult height-GaP deficit (p<0.01). Among 483,385 UKBiobank participants (mean±SD age: 56±8 years at height-GaP assessment), height-GaP deficit was associated with death from all-causes (adjusted hazard ratio comparing highest-to-lowest height-GaP deficit quartile [aHR]:1.25 95%CI:1.21-1.29), atherosclerotic cardiovascular disease (aHR:1.33 95%CI:1.24-1.43) and coronary heart disease (aHR:1.68 95%CI:1.52-1.86). Early- and later-life height-GaP associations replicated in DMHDS and MESA. INTERPRETATION: This study introduces a simple index of early-life growth adversity deployable in adulthood to investigate the developmental origins of longevity and improve health equity across the life course. FUNDING: Federal agencies and academic institutions.

Duke Scholars

Published In

medRxiv

DOI

Publication Date

June 17, 2025

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldman-Pham, R., Alter, M. P., Bao, R., Collins, S. É., Debban, C. L., Allinson, J. P., … Smith, B. M. (2025). Quantifying the impact of early-life growth adversity on later-life health. MedRxiv. https://doi.org/10.1101/2025.06.16.25327714
Goldman-Pham, Raphael, Matthew P. Alter, Rebecca Bao, Sophie É. Collins, Catherine L. Debban, James P. Allinson, Antony Ambler, et al. “Quantifying the impact of early-life growth adversity on later-life health.MedRxiv, June 17, 2025. https://doi.org/10.1101/2025.06.16.25327714.
Goldman-Pham R, Alter MP, Bao R, Collins SÉ, Debban CL, Allinson JP, et al. Quantifying the impact of early-life growth adversity on later-life health. medRxiv. 2025 Jun 17;
Goldman-Pham, Raphael, et al. “Quantifying the impact of early-life growth adversity on later-life health.MedRxiv, June 2025. Pubmed, doi:10.1101/2025.06.16.25327714.
Goldman-Pham R, Alter MP, Bao R, Collins SÉ, Debban CL, Allinson JP, Ambler A, Bertoni AG, Caspi A, Lovinsky-Desir S, Ekstrom MP, Engert JC, Jacobs DR, Malinsky D, Manichaikul A, Michos ED, Moffitt TE, Oelsner EC, Ramrakha S, Rich SS, Sack C, Stanojevic S, Subbarao P, Sugden K, Theodore R, Watson KE, Williams B, Yang B, Dupuis J, Shaheen SO, Barr RG, Hancox RJ, Smith BM. Quantifying the impact of early-life growth adversity on later-life health. medRxiv. 2025 Jun 17;

Published In

medRxiv

DOI

Publication Date

June 17, 2025

Location

United States